skyrizi and tirzepatide FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Skyrizi?? Cool name... is it

(2019) 177:88195 e17

3.2.5 Treatment of central nervous system disorders Spinal cord injury (SCI), characterized by sensory and motor dysfunction, continues to pose major clinical challenges because of the limited therapeutic efficacy of current treatment paradigms (Kunte et al., 2015)

[11] Comparison of Consensus Guidelines and Targets Professional societies offer varying recommendations based on patient risk profile: National Lipid Association (NLA): The 2024 NLA expert consensus on ApoB recommends treatment thresholds of 60 mg/dL (very-high risk), 70 mg/dL (high risk), and 90 mg/dL (borderline-to-intermediate risk), and classifies ApoB 130 mg/dL (90th percentile) as a risk-enhancing factor

Clinical studies demonstrate that semaglutide weight loss treatments can lead to reductions of 15% to 20% in body weight when used in combination with lifestyle changes

GLP-1s for weight loss are typically given as a once-weekly injection

Their also so informative about what todo so Peter R I absolutely love Synergy